+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years - 85Years
MALE
ID07339267

Evaluating Safety and Drug Levels of ASP5541 with Prednisone and Hormone Therapy in Chinese Men with Advanced Prostate Cancer

Led by Astellas Pharma Global Development, Inc. · Updated on 2026-10-26

12

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

This research aims to study Chinese men with prostate cancer by evaluating the safety and how the drug ASP5541 travels through the body when given with prednisone and androgen deprivation therapy ADT. The study focuses on men with advanced prostate cancer, including metastatic hormone-sensitive and castration-resistant types, to see how these treatments work together under medical observation. Participants will receive ASP5541 as an injection into the muscle near the hip every 12 weeks. Alongside this, they will take prednisone orally once or twice daily depending on their cancer subtype, and continue ADT as standard care. The treatment with ASP5541, prednisone, and ADT will continue until the cancer worsens or the doctor decides to stop the study treatment. Throughout the study, participants will undergo regular assessments including blood tests to measure drug levels and observe side effects, physical exams, vital sign checks, and imaging scans to monitor cancer progression. Researchers will track safety, drug behavior in the body, prostate-specific antigen levels, testosterone levels, and overall health status over several months. The study may last up to 33 months, allowing long-term monitoring of effects and safety.

CONDITIONS

Brief Title

A Study to Evaluate the Safety and Drug Levels of ASP5541 in Chinese Participants With Prostate Cancer

Research Team

A

Astellas Pharma Global Development, Inc.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here